Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Mengge Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1337-1823; OpenAlex author ID A5101861538. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 5

  1. Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer-related gene in pancreatic cancer. Co-author DOI 10.1002/ctm2.70424↗
  2. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Co-author DOI 10.3389/fonc.2021.634167↗
  3. Corrigendum: E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Co-author DOI 10.3389/fonc.2021.693855↗
  4. Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling. Co-author DOI 10.7150/jca.37762↗
  5. Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer. First author DOI 10.7150/thno.38704↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yu Gan · 5 shared papers, 2020–2025 · strength 0.64
  2. Hong Tu · 5 shared papers, 2020–2025 · strength 0.64
  3. Jin Li · 3 shared papers, 2021–2025 · strength 0.43
  4. Hui Cong · 3 shared papers, 2021–2025 · strength 0.43
  5. Yiyi Liang · 2 shared papers, 2021 · strength 0.22
  6. Yuan Fang · 2 shared papers, 2021 · strength 0.22
  7. Zhigang Zhang · 2 shared papers, 2020 · strength 0.21
  8. Yongwei Sun · 1 shared paper, 2025 · strength 0.20
  9. Dejun Liu · 1 shared paper, 2025 · strength 0.20
  10. Dengfei Xu · 1 shared paper, 2020 · strength 0.11
  11. Yingchao Fan · 1 shared paper, 2020 · strength 0.10
  12. Qing Wang · 1 shared paper, 2020 · strength 0.10
  13. Shu‐Heng Jiang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.